(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.36%) $82.71
(6.71%) $2.05
(0.05%) $2 348.40
(-0.35%) $27.44
(4.08%) $959.75
(-0.21%) $0.933
(-0.29%) $10.99
(-0.52%) $0.796
(1.55%) $93.30
-1.67% $ 354.41
Live Chart Being Loaded With Signals
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
Dagens volum | 431 315 |
Gjennomsnittsvolum | 545 103 |
Markedsverdi | 25.94B |
EPS | $1.830 ( 2024-04-25 ) |
Neste inntjeningsdato | ( $1.920 ) 2024-07-25 |
Last Dividend | $0.200 ( 2023-11-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 46.82 |
ATR14 | $0.281 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Pucci Paolo | Buy | 564 | Common Stock |
2024-04-23 | Michels Douglas A | Buy | 564 | Common Stock |
2024-04-23 | Lai Goldman Myla | Buy | 564 | Common Stock |
2024-04-23 | Lockhart Stephen H | Buy | 564 | Common Stock |
2024-04-23 | Keller Deborah L | Buy | 564 | Common Stock |
INSIDER POWER |
---|
-9.46 |
Last 100 transactions |
Buy: 235 088 | Sell: 288 836 |
Volum Korrelasjon
West Pharmaceutical Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
West Pharmaceutical Korrelasjon - Valuta/Råvare
West Pharmaceutical Økonomi
Annual | 2023 |
Omsetning: | $2.95B |
Bruttogevinst: | $1.13B (38.28 %) |
EPS: | $7.99 |
FY | 2023 |
Omsetning: | $2.95B |
Bruttogevinst: | $1.13B (38.28 %) |
EPS: | $7.99 |
FY | 2022 |
Omsetning: | $2.89B |
Bruttogevinst: | $1.14B (39.36 %) |
EPS: | $7.88 |
FY | 2021 |
Omsetning: | $2.83B |
Bruttogevinst: | $1.18B (41.52 %) |
EPS: | $8.96 |
Financial Reports:
No articles found.
West Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.180 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.200 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0163 | 1987-01-26 |
Last Dividend | $0.200 | 2023-11-07 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-15 | |
Next Payout Date | N/A | |
# dividends | 148 | -- |
Total Paid Out | $11.05 | -- |
Avg. Dividend % Per Year | 0.18% | -- |
Score | 5.52 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.82 | |
Div. Directional Score | 9.81 | -- |
Year | Amount | Yield |
---|---|---|
1987 | $0.0676 | 1.90% |
1988 | $0.0726 | 1.70% |
1989 | $0.0776 | 1.97% |
1990 | $0.100 | 2.12% |
1991 | $0.100 | 3.30% |
1992 | $0.100 | 2.19% |
1993 | $0.103 | 1.82% |
1994 | $0.113 | 1.84% |
1995 | $0.123 | 1.79% |
1996 | $0.133 | 2.23% |
1997 | $0.143 | 2.04% |
1998 | $0.153 | 2.06% |
1999 | $0.163 | 1.86% |
2000 | $0.173 | 2.28% |
2001 | $0.183 | 2.98% |
2002 | $0.190 | 2.85% |
2003 | $0.203 | 3.29% |
2004 | $0.213 | 2.49% |
2005 | $0.225 | 1.78% |
2006 | $0.245 | 1.89% |
2007 | $0.265 | 1.04% |
2008 | $0.285 | 1.41% |
2009 | $0.305 | 1.60% |
2010 | $0.325 | 1.65% |
2011 | $0.345 | 1.65% |
2012 | $0.365 | 1.91% |
2013 | $0.385 | 1.39% |
2014 | $0.410 | 0.84% |
2015 | $0.450 | 0.86% |
2016 | $0.490 | 0.85% |
2017 | $0.530 | 0.63% |
2018 | $0.570 | 0.57% |
2019 | $0.610 | 0.63% |
2020 | $0.650 | 0.43% |
2021 | $0.690 | 0.24% |
2022 | $0.730 | 0.16% |
2023 | $0.770 | 0.33% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.194 | 1.500 | 6.12 | 9.17 | [0 - 0.5] |
returnOnAssetsTTM | 0.158 | 1.200 | 4.74 | 5.69 | [0 - 0.3] |
returnOnEquityTTM | 0.204 | 1.500 | 8.85 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.101 | -1.000 | 8.99 | -8.99 | [0 - 1] |
currentRatioTTM | 2.61 | 0.800 | 1.946 | 1.556 | [1 - 3] |
quickRatioTTM | 1.736 | 0.800 | 4.49 | 3.59 | [0.8 - 2.5] |
cashRatioTTM | 0.928 | 1.500 | 5.95 | 8.93 | [0.2 - 2] |
debtRatioTTM | 0.0851 | -1.500 | 8.58 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 76.61 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.29 | 2.00 | 6.57 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.25 | 2.00 | 7.37 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.114 | -1.500 | 9.54 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.372 | 1.000 | 7.14 | 7.14 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.220 | 1.000 | 7.61 | 7.61 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.47 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.813 | 0.800 | 7.91 | 6.33 | [0.5 - 2] |
Total Score | 12.80 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 46.58 | 1.000 | 5.40 | 0 | [1 - 100] |
returnOnEquityTTM | 0.204 | 2.50 | 9.26 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.25 | 2.00 | 8.25 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.219 | 1.500 | 4.52 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.29 | 2.00 | 6.57 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.101 | 1.500 | 8.99 | -8.99 | [0 - 1] |
pegRatioTTM | 4.17 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.258 | 1.000 | 6.04 | 0 | [0.1 - 0.5] |
Total Score | 6.82 |
West Pharmaceutical
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.